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Abstract 
 
Many doors were opened for the field of genetics by the discovery of dsRNA-mediated gene 
silencing, also known as RNA interference (RNAi). This potent scientific tool has led to 
many great discoveries and holds much potential for improving the world. Thus, given the 
importance of RNAi, much work is being done to better understand it. In our laboratory, 
we have discovered a spontaneous mutant that is resistant to the effects of acs-1 (RNAi) in a 
subset of tissues in C. elegans, the strain has been dubbed partially RNAi resistant (Prr). I 
have genetically mapped the mutation in this strain and characterized its mutant effect. 
The genetic evidence thus far suggest that this mutation defines a gene encoding a well-
conserved cyclophilin protein called SIG-7 that may play a role in transgene silencing 
through RNA binding. It was also determined that the Prr phenotype is most likely due to a 
general somatic gonad-specific RNAi resistance and not a resistance related solely to the 
acs-1 gene. Further investigation of this strain has potential to reveal a novel RNAi 
mechanism in C. elegans that is likely conserved in humans as well.  
 
Introduction 
 
Deoxyribonucleic acid (DNA) is the common thread that ties all living organisms together. DNA 
allows organisms to incredibly store all of the instructions that dictate an organism‟s functions, 
characteristics and more in compact molecules of DNA at the center of each cell that composes 
an organism. The entire collection of this DNA-based information is called the genome and each 
separate piece of information is stored in a discrete section of genome called a gene. Life on 
Earth follows what molecular biologists term the “Central Dogma,” coined by Francis Crick in 
1958 (Crick 1958).  In its basic form, this dogma describes the process in which DNA is 
transcribed into a messenger molecule called messenger ribonucleic acid (mRNA) and this 
mRNA is translated into a functional protein that carries out instructions dictated by the original 
DNA gene. Manipulating different aspects of this process in any organisms offers researchers to 
explore almost every aspect of an organism. This exploration involves the simple idea of gene 
silencing; if a researcher is able to block the expression of a specific gene at any level of the 
dogma (DNA, RNA or protein), she can observe the effect and learn much about the gene. This 
information could reveal much about the mRNA and protein the gene encodes for, the pathways 
and processes that the protein plays a role in, the importance of these pathways and processes 
and more. Thus, it is evident that inhibiting gene expression can provide a wealth of information. 
 
RNA Interference is a Powerful Genetic Tool 
In 1998, Dr. Andrew Fire and Dr. Craig Mello made the astonishing discovery that the 
expression of double-stranded RNA (dsRNA) could trigger sequence-specific gene silencing in 
the model organism Caenorhabditis elegans (informally referred to as „worms‟) (Fire et al., 
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1998). New doors were opened for the field of genetics when it was found that this process of 
gene-silencing, referred to as RNA Interference (RNAi), was actually conserved among many 
organisms including Drosophilia, plants, fungi and even mammalian cells (Kennderdel and 
Carthew 1998; Ngo 1998; Bosher 2000). The fact that mammalian cells were susceptible to 
RNAi was truly exciting because mammals are difficult to carry out forward genetic experiments 
with and do not work well with other gene targeting experiments (Paddison and Vogt 2008). 
With the ability to specifically knock down the expression of nearly any gene and whole genome 
sequences available for almost every organism, RNAi has proven to be potent tool for scientific 
discovery. For instance, genome-wide RNAi screens have enabled researchers to identify key 
cell cycle regulators in yeast, investigate programmed cell death in C. elegans and study host 
pathogen response in mammalian cells (Hartwell et al. 1974; Horvitz et al. 1999; Hong-Geller 
and Micheva-Viteva 2010). RNAi enables researchers to identify and characterize enigmatic 
genes involved in a multitude of processes, making RNAi a truly remarkable scientific tool. 
 
Given the recent research, RNAi may prove to have even more beneficial applications in 
addition to acting as an effective laboratory technique. In plants, work has been done to utilize 
RNAi in combination with genetic engineering to increase plant productivity and augment 
protein production, which would make plants more nutritious for developing countries, by 
controlling the expression of transgenic and endogenous genes (reviewed in Tang et al. 2004). 
RNAi is also currently being considered for therapeutic uses in medicine. The thought is that 
RNAi could be used to knock down pathogenic gene expression that causes illness thus 
providing a more specific and effective method to treat diseases such as viral infection and even 
cancer. There are of course complications in this field regarding administration of RNA as a drug 
and how the body will react to it, but the concept holds a lot of promise for novel therapeutic 
drugs (Sah et al. 2006; Zimmermann et al. 2006). Evidently, RNAi is a powerful cellular 
mechanism that has significant potential for improving the world we live in. 
 
The Mechanism of Gene Silencing induced by Double Stranded RNA 
What is known about RNAi today is that much of the machinery and mechanisms is well 
conserved among organisms and that there a several types of RNA involved (reviewed in 
Paddison and Vogt 2008; Bartel 2002). One of the primary roles of RNAi in eukaryotes is 
thought to be protection against foreign genetic material. This defense mechanism begins with 
the binding of dsRNA that is bound by the protein Dicer, a member of the RNase III family. 
Dicer cleaves the dsRNA into a smaller double-stranded RNA that is about 18-25 nucleotides in 
length with two nucleotide overhang on 3‟end. This shorter dsRNA is called small-interfering 
RNA or siRNA. This siRNA is then unwound and one strand is incorporated into the RNA-
induced silencing complex (RISC) while the other is degraded. The most important members of 
the RISC complex are the Argonaute proteins that have a PAZ domain that can bind siRNA and 
a PIWI domain that conveys the catalytic ability to cleave the target mRNA. Other proteins 
involved in the RISC complex are currently under investigation, some proposed proteins include 
VIG and Fragile X-related protein and the nuclease Tudor-SN, which are all RNA-binding 
proteins. After incorporation into the RISC complex, the now single stranded siRNA then binds a 
complementary, target mRNA and brings the RISC complex along. The Argonaute proteins of 
the RISC complex then cleave the mRNA in the middle of where the siRNA binds it and a 
nuclease recognizes this cleaved mRNA as foreign and degrades it. Thus, the degradation of this 
mRNA silences the expression of the gene it was associated with.  
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Gene silencing through dsRNAs also plays a role in the regulation of an organism‟s own genetic 
material especially in regards to development. Signals to regulate these genes result in the 
transcription of endogenous dsRNAs. These endogenous dsRNAs are called primary micro 
RNAs (pri-miRNAs) and they are actually gene products that are transcribed in the nucleus and 
transported to the cytoplasm to be processed by Dicer and result in gene silencing. The genes 
that encode these pri-miRNAs do not code for proteins. Pri-miRNAs are transcribed from these 
non-coding genes and cleaved into pre-miRNAs by Drosha, another member of the RNase III 
family. These endogenous pre-miRNAs are cleaved into microRNAs (miRNAs) by Dicer and it 
is these miRNAs, not siRNAs, which lead gene silencing. The mechanism that miRNAs use for 
silencing the cell‟s own genes is slightly different from the mechanism used for silencing foreign 
genetic material. After unwinding into single stranded miRNA and being incorporated into the 
RISC complex, these miRNAs imperfectly bind to target RNAs (siRNAs tend to bind their 
targets perfectly) which can lead to not only degradation but also translational inhibition or 
transcriptional silencing. What dictates the mode of silencing is currently under investigation. 
The two different pathways for gene silencing with dsRNAs are illustrated in Figure 1.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The current model for gene silencing via dsRNA (Taken from http://www.dolcera.com) 
  
Unique Aspects of RNA Interference in C. elegans 
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While the mechanism of RNAi is conserved in many organisms, there are variations on the 
process that can be unique to certain creatures. RNAi in C. elegans for one has many distinctive 
characteristics that are not found in most organisms. The two main aspects that make RNAi 
unique in C. elegans is that RNAi is transitive in worms, meaning it can amplify siRNAs and 
silence mRNA upstream from the original sequence-specific target, and RNAi is systemic, 
meaning  it can spread from the tissue of origin to another tissue and from parent to progeny 
(Fire et al. 1998). The only other organisms that have been identified thus far to share these traits 
are plants (Palauqui et al. 1997; Fagard et al. 2000). There has been much work done to identify 
the genes and proteins involved in conveying these distinct characteristics of RNAi in worms.  
 
A major discovery in determining what conveys the transitive property of RNAi in worms was 
the characterization of an RNA-directed RNA Polymerase (RdRP) homolog, RRF-1 (Fire et al. ). 
This protein is able to amplify the effect of RNAi by essentially using siRNA produced by the 
initial dsRNA trigger as a primer to make new siRNAs that work further upstream from the 
original RNA target site. It is this transitive amplification process that contributes to the potency 
of RNAi in worms (Sijen et al. 2001; Alder et al. 2003). Figure 2 illustrates the mechanism of 
RRF-1 (referred to as RdRP) in worms. In regards to the systemic nature of RNAi in C. elegans, 
the identification and characterization of the SID-1 protein by Dr. Winston and his colleagues in 
the Hunter lab revealed much about the mechanism of this phenomenon. This protein was found 
to be a trans-membrane protein involved in the transport of dsRNA from cell to cell. It has been 
proven to be necessary for the spread of the effects of RNAi from tissue to tissue and from parent 
to progeny that is so unique in worms. While there is no current evidence of systemic properties 
of RNAi in Drosophila there is still a chance that some of these properties are conserved in 
humans and mice based on the fact that there are proteins similar to SID-1 in both of these 
organisms (Winston et al. 2002; Feinberg and Hunter 2003). Thus, identifying the factors that 
relate to this phenomenon of systemic RNAi could contribute to a wide range of scientific fields.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Seng 5 
 
 
 
 
 
 
 
Figure 2: The mechanism of RdRP in transitive RNAi amplification in worms (Adapted from 
Ghildiyal and Zamore 2009) 
 
An unknown mutation that conveys partial resistance to RNAi of the acs-1 gene 
Dr. Marina Kniazeva, a post-doc in our laboratory, made a rather serendipitous discovery when 
using what she thought was an N2 Bristol, or wild-type strain, from another laboratory. 
Surprisingly, this strain ended up being partially resistant to the RNAi of a gene called acs-1, 
which she later determined was due to a spontaneous mutation in that animal‟s genome.  acs-1 
encodes for a very long chain acyl-CoA sythetase that is necessary to synthesize and activate a 
monomethyl branched-chain fatty acids (mmBCFAs), specifically C17ISO. C17ISO is necessary 
for worm growth and development (Kniazeva et al. 2008). The unknown mutant strain is 
informally referred to as partially RNAi resistant (Prr) and we say “partially” because it appears 
to require C17ISO supplementation to resist the effects of acs-1 (RNAi). Without C17ISO this 
strain exhibits the same phenotype as wild-type worms, L3 larval arrest, when exposed to acs-1 
(RNAi). However unlike wild-type worms, Prr worms can grow to adulthood and have many 
generations of healthy-looking progeny when fed acs-1(RNAi) with C17ISO. Usually, wild-type 
worms can grow to adults when exposed to acs-1 (RNAi) with C17ISO supplementation; 
however, embryos in the next generation never hatch (Figure 2) (Kniazeva, unpublished data). 
The focus of this project is to answer the following question: Is this RNAi resistance in Prr 
mutant worms specific to acs-1 or is related to the process of RNAi overall? To answer this 
question, I needed to identify the gene affected by the Prr mutation and characterize its effects. 
Determining the nature of the Prr mutation has the potential to reveal new characteristics of the 
acs-1 gene or expose novel aspects of the RNAi mechanism in C. elegans.  
 
 
 
Figure 2: The effect of acs-1(RNAi) with a C17ISO supplement on Prr worms (Left) and N2 worms 
(Right). Both worms were plated as embryos on acs-1 (RNAi) + C17ISO and allowed to grow to the adult 
Prr on acs-1(RNAi) +C17ISO N2 on acs-1(RNAi) +C17ISO 
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stage and lay eggs. Pictures were taken 6 days after the P0 worms hatched. On the left, the Prr F1 
generation is already hatched and at the L2-L3 larval stage and growing whereas on the right, the N2 F1 
embryos are arrested (black arrows).  
 
 
Materials and Methods 
 
RNA Interference via feeding  
The RNAi feeding vectors were obtained from the C. elegans whole genome RNAi feeding library (J. Ahringer, 
MRC Geneservice, Cambridge, United Kingdom). The RNAi feeding strain was E. coli HT115 transformed with 
with dsRNA-producing constructs. Plates were prepared as described in Kamath et al. (2001). acs-1 (RNAi) plates 
with C17ISO supplements were made by adding 100 mM C17ISO to RNAi plates for a final concentration of 1mM 
C17ISO. Unless otherwise stated, after the plates dried overnight at room temperature, gravid worms were bleached 
and their embryos were placed on RNAi plates and allowed to hatch and grow. Alternatively, adults worms were 
also placed on RNAi plates and allowed to lay eggs then killed and their progeny were observed. 
 
SNP Mapping 
Single nucleotide polymorphisms (SNPs) throughout the C. elegans genome were used to determine where in C. 
elegans genome the Prr mutation lies. Chromosomal mapping and interval mapping were carried out using the 
protocol described by Davis et al. (2005). Chromosome mapping was carried out by first crossing Prr 
hermaphrodites at the L4 larval stage and with male Hawaiian (HA) worms with a green fluorescent protein gene 
(GFP) integrated into the X chromosome. Green worms were picked from the F1 generation, the GFP expression 
indicating that the worms were heterozygous for N2 and HA chromosomes. About 10 F1 worms were picked as 
L4‟s onto acs-1 (RNAi) plates supplemented with 1mM C17ISO and allowed to lay eggs which were allowed to 
hatch. This ensured that F2 progeny were continuously exposed to acs-1 (RNAi) and the F1 L4‟s were unaffected by 
RNAi. About 200 F2 progeny were then singly picked at the L3-L4 stage onto new acs-1 (RNAi) plates with 
C17ISO and allowed to grow and propagate. These plates were screened to see if the F3 generation was able to 
hatch, indicating a homozygous Prr mutation, or if the F3 embryos arrested. The F2‟s expressing the Prr mutation 
and their progeny were pooled together and lysed for their DNA. This DNA was amplified with PCR for each SNP 
location (see protocol in Davis et al. (2005) for PCR reaction details and primers) and digested for 6 hours at 37 C 
with the restriction enzyme DraI. The bands from the PCR and restriction digest were then analyzed using gel 
electrophoresis on 2% agarose gel. 
 
For interval mapping, the same cross and plating techniques in chromosome mapping were used to obtain F2 worms 
that expressed the Prr phenotype. The F2 worms along with their self-progeny were tested to confirm Prr 
homozygosity by plating embryos from the F2 plates onto new acs-1 (RNAi) plates with C17ISO and screening for 
the Prr phenotype. The F2 plates that passed this test were individually lysed and frozen as template DNA. About 96 
F2‟s along with their progeny were collected. The template DNA was then pin replicated into PCR reactions with 
primers for each SNP (see Davis et al. (2005) for I:-1, I:5 and I:13; I:2.861: FORWARD 
5‟TCAAATTTGGCACGTCATCAG3‟ and REVERSE 5‟CTCCATTTTGGAACTCCCAG3‟) and PCR products 
for I:-1, I:5 and I:13 were digested with DraI restriction enzyme and PCR products for I:2.861 were digested with 
EcoRI restriction enzyme for 6 hours at 37 C. DNA bands were visualized using gel electrophoresis on a 2% agarose 
gel.  
 
Three-Point Mapping 
The flanking markers used to map Prr were unc-13(e1091), which has an uncoordinated (Unc) phenotype that can 
barely move, and dpy-24(s71), which has a dumpy (Dpy) or short and fat phenotype. Both mutations are on 
chromosome I and unc-13(e1091)is at 2cM and dpy-24(s71) is at 4.72 cM; they flank the general region where the 
Prr mutation is thought to be located. unc-13(e1091) dpy-24(s71) worms were tested on acs-1 (RNAi) plates with 
and without C17ISO and were susceptible to the effects. unc-13(e1091) dpy-24(s71) hermaphrodites were crossed to 
Prr males and the resulting F1 generartion heterozygotes were singly picked onto plates and allowed to self-
fertilized. The resulting F2 generation was screened for recombinants that were either Unc non-Dpy or Dpy non-
Unc. Recombinant progeny were singly picked and allowed to propagate. Then F3 embryos from each recombinant 
were picked onto acs-1(RNAi) plates supplemented with C17ISO and screened for the Prr phenotype. F2 progeny 
that throw either Prr or non-Prr were scored and used to determine recombination frequency (Figure 5).  
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Whole Genome Sequencing 
 Worms with the Prr mutation were grown on large, 10 cm NGM plates seeded with concentrated OP50 E. coli 
bacteria. Worms were collected and their genomic DNA was extracted with a Qiagen DNeasy Blood and Tissue Kit. 
The genomic DNA was purified and ligated to sequencing adapters using an Illumina DNA preparation kit. DNA 
was sent out to the High-throughput DNA sequencing facility at CU Denver for single molecule sequencing.  
 
Gene Sequencing 
 N2 and Prr worms were lysed in lysis buffer and their raw genomic DNA was collected. This DNA was sequenced 
for the presence of a mutation in the following genes: F39H2.2, F36H2.2 and C04F12.8, as indicated by Whole 
Genome Sequencing data. The primers used to amplify the mutated regions for each gene via PCR were: 
F39H2.2:FORWARD 5‟ TGGACAATGTTCTTATTGATGATC3‟ and REVERSE 5‟TCACGACGATCACGGTTG 
3‟, F36H2.2: FORWARD 5‟TATGGGTTTTTCAACAGAAATT 3‟ and REVERSE 
5‟CTTGAGGTTTTTTATTTGAAA 3‟and C04F12.8: FORWARD 5‟GTTTTTACTTTTTTTTTCTCTTTTGTG 3‟ 
and REVERSE 5‟ AAACACCCCAATCCACCA3‟. PCR products were then run on a 2% agarose gel and purified 
using a QIAquick Gel Extraction Kit (Qiagen). 2uL of the purification products were sent down with 3.7 uL of 
forward primer for each mutation to be analyzed by the DNA Sequencing facility of Department of MCDB at 
University of Colorado 
 
Preliminary Data 
Dr. Kniazeva was able to conduct a few experiments to characterize the Prr mutation. She first 
tested to see if Prr was resistant to the silencing of any other genes with RNAi. Her results are 
recorded in the following table: 
 
 
 
Table 1:  A selective response of acs-1PrTnsl::GFP
Prr
 strain to RNAi-treatment. (Kniazeva) 
               Gene             RNAi Phenotype      Process Tissue, GFP 
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target or EST* 
Cosmid 
name 
Gene  
name 
N2  acs-
1PrTnsl::GFP
Prr
 
B0336.2 arf-1,2 sterile (Ste), protruding vulva 
( pvl), ruptured (rup) 
wt ADP-ribosylation 
factor 
Gut, neuron, uterus, 
spermatheca, 
gonadal sheath, 
muscles, pharynx, 
hypodermis 
C02C6.1 dyn-1 L4 larval lethal (lvl) wt dynamin GTPase; 
locomotion, egg-
laying, defecation, 
and cytokinesis, 
embryonic 
development 
neurons, 
spermatheca,gonadal 
sheath cells, 
coelomocyts and 
apical surface of 
intestinal cells, 
hypodermal cells  
 C23H3.4 sptl-1 Pale, small (sma), egg-laying 
variant (egl),  embryonic 
lethal (emb), early lvl 
P0: wt 
F1: L1-L2 arrest 
Sphingolipid 
metabolism 
L1, L2, L4, embryo* 
C56C10.8 icd-1 ste ste Apoptosis nerve ring, pre-anal 
ganglion,  intestinal 
and germ cells 
F32H2.5 fasn-1 L2  lvl L2/L3 lvl FA metabolism L1, L2, L4, embryo* 
F32H2.6 fasn-2 late emb wt FA metabolism embryo* 
F41H10.7 elo-5 Po: egl, F1: L1 arrest Po: egl, F1:  
L1 arrest 
mmBCFA 
metabolism 
gut, neurons 
              Gene target             RNAi Phenotype      Process 
 
Tissue, GFP 
or EST* 
 
Cosmid 
name 
Gene  
name 
N2  acs-
1PrTnsl::GFP
Prr
 
F46e10.1 acs-1 L3 lvl L3 lvl mmBCFA metabolism 
 
gut, neurons, gonadal 
sheath  F46E10.1 acs-
1
C17ISO
    
early emb, 
cytokinesis, 
100% 
wt 
H39E23.1 par-1 low emb high emb Embryonic polarity body wall muscle; 
nervous system, 
embryo  
K04D7.1 rack-1 part ste part ste Receptor of activated C 
kinase 
L1, L2, L4, embryo* 
K07C5.4 n/a pvl,  Strong pvl nucleolar protein L1, L2, L4, embryos* 
K08E3.6 cyk-4 ste, pvl Po: wt 
F1: emb 
Gonad and embryonic 
morphogenesis, cell 
polarity in embryos and 
gut 
pharynx;  gut, 
reproductive system; 
vulval muscle; 
hypodermis, embryos 
M03D2.4 zen-4 ste, emb emb kinesin-6 subfamily spindle midbody of 
all dividing cells 
M110.4 ifg-1 L4 arrest early adult arrest Translation initiation intestine, pharynx, 
neuronal ganglia, 
somatic gonad, and 
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 Table1 (Cont.):  A selective response of acs-1PrTnsl::GFP
Prr
 strain to RNAi-treatment. (Kniazeva) 
 
The GFP-expression data was taken from wormbase.org 
*the data based on cDNA sources, cited in UniGene database at http://www.ncbi.nlm.nih.gov/sites/entrez 
In bold, the wt phenotype of the acs-1PrTnsl::GFP
Prr
 treated animals  indicates a resistance to RNAi.  
 
. 
It appears that Prr worms were susceptible to most RNAi‟s but could resist the effects of RNAi 
of arf-1,2, dyn-1, sptl-1, fasn-2 and rpb-11 and were more sensitive to the effects of RNAi of 
par-1, car-1 and K07C5.4. 
 
Dr. Kniazeva was also able to integrate an extra-chromosomal array into the genomes of the Prr 
strain. This array contained a whole acs-1 gene fused to a green fluorescent protein (GFP) 
reporter and a rol-6 mutant marker, which would give worms with the integration a rolling 
phenotype. These integration strains allow us to visualize the expression of the acs-1 gene in 
worms as GFP will only be expressed where acs-1 is expressed. We also know that this 
integrated acs-1 gene is fully functional as it is able to rescue an acs-1 loss-of-function mutation 
and restore a normal, wild-type phenotype (Kniazeva, unpublished data). This strain gives us a 
very useful tool to visualize the effects of acs-1 (RNAi) on Prr worms. Adult Prr worms with the 
integrated plasmid were placed onto plates with acs-1 (RNAi) with C17ISO supplement and 
HT115 E. coli transformed with an empty vector as a control. F1 progeny were then screened for 
ACS-1::GFP expression with a fluorescent microscope. It was found that in Prr worms fed 
HT115, ACS-1::GFP was expressed in the intestine and somatic gonad which is where ACS-1 
would be found in wild-type worms (Kniazeva, unpublished data). Interestingly, when fed acs-1 
(RNAi) with the C17ISO supplement Prr only lost ACS-1::GFP expression in intestine and 
retained expression in the somatic gonad (Figure 3) (Kniazeva, unpublished data). 
 
 
 
 
 
 
body wall muscle 
T05H4.6 phi-1 emb emb Peptide chain release 
factor 1 (eRF1) 
L1, L2, L4, embryo* 
T05H10.6 pdh-1 emb 
 
emb 
 
Pyruvate metabolism L1, L2, L4, adult, 
embryo* 
W01B11.3 nol-5 pvl, ste pvl, ste Ribosome biogenesis L1, L2, L4, embryo* 
W01G7.3 rpb-11 50% rup, sck, 
ste 
wt RNA polymerase, subunit 
L 
embryo, L1 larvae*  
ZK617.1 unc-22 twitcher, 
100% 
twitcher, 100% locomotion intestine, body wall 
muscles 
Y18D10A.17 car-1 low emb high emb Oogenesis, embryonic 
cytokinesis, ER 
organization 
germline, embryos 
3A) Prr Int[acs-1::GFP; rol-6] on HT115 +empty vector 
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Figure 3: Visualization of Prr Int[acs-1::GFP;rol-6] A) GFP fluorescence is present 
throughout the intestine (black arrows) and somatic gonad (white arrow) 
 
 
 
 
 
 
 
 
 
 
 
 
 
3B) Prr Int[acs-1::GFP; rol-6] on acs-1(RNAi) +C17ISO 
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Figure 3 (cont.): Visualization of Prr Int[acs-1::GFP;rol-6] B) Black arrows point at intestine 
and white arrows point at somatic gonad. GFP fluorescence in absent in the intestine (rightmost 
picture) only auto-florescence of lipids can be seen. However, GFP is still present in the somatic 
gonad (leftmost and middle pictures). All pictures were taken of worms at the adult stage. Top 
pictures show worms underneath fluorescent light and bottom shows reference picture under 
regular light. All pictures taken at the same exposure. (Kniazeva) 
 
 
 
 
 
Results 
 
Additional RNA Interference Assays 
To determine whether or not the RNAi resistance in Prr mutants was unique to acs-1 (RNAi) and 
to characterize the Prr strain, I repeated several RNAi assays performed by Dr. Kniazeva and 
also performed a few of my own. N2 worms were used as a control for the RNAi tests and both 
N2 and Prr adults were picked onto several different RNAi plates in duplicate and they were 
killed after laying several eggs and their progeny were observed. These progeny were considered 
the P0 generation in all of the RNAi assays. The following table depicts the results of this assay. 
 
 
 
 
 
Table 2: The Effects of RNAi of Various Genes in Prr worms 
Gene Target 
(sequence 
name) 
RNAi Phenotype Tissue(s) 
affected  
Process* 
N2 Prr 
elo-5 
(F41H10.7) 
P0: egl, F1: L1 
larval arrest 
P0: egl, F1: L1 
larval arrest 
gut, neurons mmBCFA metabolism 
unc-22 
(ZK617.1) 
twitcher, 
locomotion variant 
twitcher, 
locomotion 
variant 
muscle required in muscle for regulation of 
the actomyosin contraction-
relaxation cycle and for maintenance 
of normal muscle morphology 
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gon-1 
(F25H8.3) 
 sterile, 
exploded through 
vulva, protruding 
vulva 
wild-type somatic gonad, 
neurons, muscle 
hermaphrodite gonadal 
morphogenesis; sequence homology 
with other metalloproteases suggests 
that it functions by remodelling the 
extracellular matrix 
fkh-6 
(B0286.5) 
egg laying variant, 
protruding vulva, 
maternal sterile 
 
wild-type somatic gonad fkh-6 is required for several aspects 
of male gonadogenesis 
mex-3 
(F53G12.5) 
embryonic lethal embryonic lethal adult distal 
gonad, mature 
oocytes, and 
early 1-cell stage 
embryos 
required for specifying the identities 
of the anterior AB blastomere and its 
descendants, as well as for the 
identity of the P3 blastomere and 
proper segregation of the germline P 
granules 
dpy-11 
(F46E10.9) 
dumpy dumpy hypodermal cells  affects body shape and ray 
morphology 
par-1 
(H39E23.1) 
vulva morphology 
variant, P0 sterile 
low brood size, P0 
sterile later on, 
F1 larval arrest 
body wall 
muscle; nervous 
system, embryo  
Embryonic polarity 
pha-4 
(F38A6.1) 
low brood size, 
protruding vulva 
low brood size, 
protruding vulva 
pharynx, 
intestine, somatic 
gonad (later in 
development) 
necessary and sufficient for 
development of the pharynx/foregut 
dyn-1 
(C02C6.1) 
L4 larval lethal P0 low brood size, 
F1 larval arrest 
neurons, 
spermatheca,gon
adal sheath cells, 
coelomocyts and 
apical surface of 
intestinal cells, 
hypodermal cells 
dynamin GTPase; 
locomotion, egg-laying, defecation, 
and cytokinesis, embryonic 
development 
sptl-1 
(C23H3.4) 
Pale, small, egg 
laying defect,  
embryonic lethal, 
early larval lethal 
wild-type L1, L2, L4, 
embryo 
Sphingolipid metabolism 
*Descriptions of processes obtained from Wormbase.org. Bold genes are repeated experiments 
Wild-type indicates RNAi resistance. Italicized phenotypes indicate different from N2 phenotype 
 
RNAi of genes that resulted in no phenotype for both N2 and Prr were excluded from the data. 
Based on these observations, it appears that Prr worms are susceptible to the knocking down of 
most of the genes through RNAi except for gon-1, fkh-6 and sptl-1. Prr worms also have less 
severe phenotypes for RNAi of dyn-1 and par-.1 
SNP Mapping to Identify the Location of the Prr Mutation in the C. elegans Genome 
The first step in determining the identity of the gene affected by the Prr mutation is to identify 
the location of the mutation. To do this, I took advantage of single nucleotide polymorphisms 
(SNPs) that exist in two different strains of C. elegans: the wild-type, N2 Bristol strain (N2) and 
the CB4856 strain also known as Hawaiian (HA). These SNPs can actually act as genetic 
markers to distinguish one strain‟s DNA from the other. This is especially effective if the SNPs 
affect restrictions sites and thus result in different sized fragments when either N2 or HA DNA is 
cut by the same restriction enzyme. For most of the SNP Mapping, I followed the protocol set 
out by Davis et al. (2005).  
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The Prr mutation is in an N2 background so any SNPs surrounding the Prr mutation should be 
linked to N2. I used this linkage to first identify which chromosome held the Prr mutation. After 
re-isolating the homozygous Prr mutation in an HA background by crossing Prr worms and HA 
worms (see Materials and Methods), I could now analyze the SNPs on all of the worm 
chromosomes (I, II, III, IV, V and X). I expected to see both HA and N2 SNPs being expressed 
equally throughout the genome due to random recombination events except on the chromosome 
where the Prr mutation lies because the gene is only mutated in N2 and thus, the area close to the 
mutation would have primarily N2 SNPs. Using heterozygous F1 worms and their progeny as a 
control, which have equal amounts of N2 and HA SNPs, I was able to find N2 linkage at 
chromosome I for worms re-isolated with the Prr mutation after being crossed with HA worms 
(Figure 4A).  
 
After some trial and error, the process of isolating mutants for SNP Mapping also enabled me to 
also define the mutation as recessive. For a recessive mutation, I expected 1/4 of the total F2‟s 
picked from the F1 self-cross to be Prr homozygous. At first I was getting ratios that were much 
higher, close to 3/4 and led to the suspicion that this mutation was dominant. However, after 
using a HA strain with GFP integrated into the X chromosome, I was able to ensure that the F1‟s 
picked were heterozygous for N2 and HA SNPs and the ratio of Prr worms to total F2‟s picked 
was about 1/4. It turned out the problem was I was picking self-progeny from the Prr 
hermaphrodites as well as cross progeny in the F1 generation which led to an inflated number of 
Prr mutants in the F2 generation. Also, I wouldn‟t be able to get a result from SNP mapping if 
the mutation could express a phenotype in the heterozygous form as no N2-linkage would be 
evident, thus adding to the conclusion that the Prr mutation is recessive.  
 
After determining that the Prr mutation was on chromosome I, interval mapping with SNPs was 
used to refine the position of the Prr mutation on that chromosome. The same cross for interval 
mapping was performed, except that F2‟s with the Prr mutation were lysed separately and 
analyzed individually for their SNP‟s. The idea here is that for the most part, SNPs that lie on 
chromosome I will be N2 homozygous for Prr worms because as stated before the Prr mutation is 
linked to the N2 SNPs. However, recombination events will spontaneously occur between the 
HA chromosome and the N2 chromosome in the F1 generation which will lead to a recombinant 
F2 progeny expressing the Prr mutation along with a HA SNP at a certain location on 
chromosome I. These kinds of recombination events will occur less frequently the closer you get 
to the Prr mutation because it is tightly linked to any nearby N2 SNPs. So analyzing the different 
SNPs along chromosome I for each Prr mutant re-isolated from the Prr x HA cross will help 
determine where on chromosome I the Prr mutation lies.  
 
96 Prr mutants were isolated from the Prr x HA cross and re-tested on new acs-1 (RNAi) plates 
supplemented with C17ISO to ensure that they were indeed homozygous for Prr and the plates 
did not just fail. Each of these mutants were lysed for their DNA and analyzed for SNPs at -1 
cM, 2.861 cM, 5 cM and 13 cM on chromosome 1. The data was normalized to the number of 
samples where the all four SNPs could be analyzed which gave a total of 61 samples. Based on 
the frequency of recombination at each of these SNPs that resulted in both HA and N2 SNPs 
being expressed, the Prr mutation was thought to lie between 2.861 and 5 cM (Figure 4B). 
 
I 
 
II 
 
III 
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Figure 4:  A) Results of chromosome mapping. Blue W indicates control samples, Red M indicates Prr samples, 
White L indicates 1Kb+ ladder and yellow dots indicate N2 linkage on chromosome I. It is obvious that there is only 
linkage apparent on chromosome I. B) Results of interval mapping. Given the recombination frequencies, it is 
evident that the Prr mutation lies between 3cM and 5cM on chromosome I (asterisk). Blue lines indicate N2 SNPs 
and red lines indicate HA SNPs       
 
Refining the Genetic Position of the Prr Mutation with Three-Point Mapping 
With a chromosome and a region defined for the location of the Prr mutation, a more exact 
location can be identified using three-point mapping. Three-point mapping involves using two 
genetic markers that flank a mutation and analyzing recombination frequency between these 
markers and the mutation of interest (Fay 2006). As explained before, the closer two genes are to 
each other, the less likely there will recombination events between them. The frequency of these 
recombination events is directly proportional to the genetic distance between these genes. Thus, 
creating a strain that is heterozygous for the Prr mutation and the two flanking mutations, unc-13 
and dpy-24 and quantifying the frequency of recombination events between Prr and each of the 
flanking mutations will enable me to determine a more precise location of the Prr mutation (see 
Figure 5 and Materials and Methods).  
 
A) 
B) 
C) 
IV 
 
  V 
 
 X 
 
* 
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Selecting for and scoring the number of recombinant self-progeny from these heterozygotes, Dpy 
non-Unc and Unc non-Dpy, enabled me to determine the frequency of recombination events 
between the flanking markers and Prr. Thus far, I have been able to isolate 14 Unc non-Dpy 
progeny and 15 Dpy non-Unc progeny. 4 out of 14 Unc non-Dpy progeny throw worms that 
express the Prr phenotype and 3 out of 15 Dpy non-Unc progeny throw worms that express the 
Prr phenotype. This preliminary data indicates that the region identified by SNP mapping is 
indeed correct and the Prr mutation must lie between 2 and 5 cM. However, many more 
recombinants need to be analyzed to provide a more concrete location. For future mapping, I will 
score at least 50 recombinants to determine the precise location of the Prr mutation.  
 
Figure 5: Three point mapping cross to identify the genetic location of the Prr mutation 
 
Utilizing Whole Genome Sequence to Identify the Gene Affected by the Prr Mutation 
To supplement the mapping data, the entire genome of the Prr worms were sent to a High-
throughput DNA sequencing facility at CU Denver to be sequenced and checked for any 
differences in sequence compared to the standard wild-type worm. Of course not every worm is 
identical, so even wild-type worms deviated from the standard. Thus, thousands of differences 
are identified through sequencing, which is why mapping is required to narrow down the list of 
candidate genes. After I obtained the specified region of 2-5 cM for the location of the Prr 
mutation, the sequencing data was analyzed for mutations in this region (Table 3). Of priority 
were the missense mutations that changed an amino acid in the gene product of a certain gene. 
There were four missense mutations in the region, two of which affected the same gene. The 
genes affected by these mutations were: F39H2.2, F36H2.2 and C04F12.8. I verified the 
mutations in these genes by sequencing the areas with the mutations in both Prr and our lab‟s 
own N2 strain, which is the parental strain for Prr. From the sequencing data, I found that two of 
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the mutated genes, F36H2.2 and C04F12.8, had the same mutations in Prr and N2 indicating that 
they were simply parental mutations and not the mutation of interest (Figure 6). The final 
mutation in F39H2.2 was actually unique to Prr, thus making it a strong candidate for the gene 
affected by the Prr mutation. This gene is more commonly referred to as sig-7 and the allele 
found in Prr worms will be referred as sig-7(ku542). 
 
Table 3: Whole Genome Sequencing Data 
All of the mutations found in the Prr worm compared to the standard wild-type sequence between 2 and 5 
cM on chromosome I are listed here. I excluded SNPs, silent mutations, heterozygous mutations and any 
mutation that was identified <10 times. The red box highlights the sig-7(ku542) mutation. 
 
 
 
 
 
 
 
 
 
Physical 
Position  
Wildtype 
Sequence 
Prr 
Sequence 
Type of 
Mutation 
Effect of Mutation on Gene Gene(s) Affected 
8395349 A T nongenic,non
genic,nongeni
c,nongenic,no
ngenic 
-2617 upstream,-3561 
upstream,514 into,606 
into,629 into 
{T19A6.1b,T19A6.1c},{T19A6.3a,T
19A6.3b},{T19A6.2b.1},{T19A6.2b.
2},{T19A6.2a,T19A6.2b.3,T19A6.2b
.4,T19A6.2c} 
8431371 A G nongenic,non
genic,nongeni
c,nongenic 
-1545 upstream,-3147 
upstream,1281 into,1444 into 
{F02E9.10a.1,F02E9.10b.2,F02E9.10
c.1},{F10D11.1.1},{F02E9.9a.1,F02
E9.9a.2,F02E9.9b.2},{F02E9.9b.1} 
8651310 G A missense AGA->AAA[Arg->Lys] {F39H2.2a,F39H2.2b.1,F39H2.2b.2} 
9235427 G A nongenic,non
genic,nongeni
c 
-1877 upstream,1258 
into,758 into 
{VF36H2L.1},{F36H2.1b},{F36H2.1
a,F36H2.1c} 
9246865 C G missense,SN
P 
CGT->CCT[Arg->Pro],none {F36H2.2},{haw8926} 
9246866 G C missense,SN
P 
CGT->GGT[Arg->Gly],none {F36H2.2},{haw8927} 
9383156 G T nongenic,non
genic 
6470 into,7153 into {F16A11.3a,F16A11.3b,F16A11.3c},
{F16A11.3d} 
9540536 C T nongenic,non
genic,nongeni
c 
-4202 upstream,-4273 
upstream,424 into 
{C36F7.2},{C41G7.7},{C36F7.1} 
9699160 T C missense,SN
P 
AAT->AGT[Asn->Ser],none {C04F12.8},{haw9282} 
9836117 A T nongenic,non
genic 
-3470 upstream,-5864 
upstream 
{Y67A6A.2a,Y67A6A.2b.1,Y67A6A
.2b.2},{Y67A6A.1} 
10037006 G T nongenic,non
genic,nongeni
c 
-2201 upstream,-9426 
upstream,6846 into 
{F10G8.5},{F10G8.6},{F10G8.7} 
10462796 G C nongenic -7172 upstream {Y106G6H.9} 
10582274 T A nongenic,non
genic 
-5891 upstream,324 into {T22A3.3a},{T22A3.2a,T22A3.2b} 
10595968 T C nongenic,non
genic 
-2730 upstream,1506 into {T22A3.5},{T22A3.6} 
) F39H2.2 
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Figure 6: Alignment of missense mutation sequences in Prr, N2 and a standard sequence A) F39H2.2 
Alignment shows that this mutation is unique to Prr and thus, not a parental mutation. B)F36H2.2 N2 and Prr share 
this mutation that deviates from the standard. C) C04F12.8 N2 and Prr share this mutation that deviates from the 
standard. Alignments shown are a few bps upstream and downstream of where mutations were expected to lie and 
red boxes indicate the identified mutations. The bottom row of each alignment shows the consensus sequence. 
I also had the idea to sequence Dpy non-Unc recombinant worms that either expressed or did not 
express the Prr phenotype for the sig-7(ku542) mutation. Interestingly, Dpy non-Unc worms with 
that expressed the Prr phenotype also had the sig-7(ku542) and those that did not express the Prr 
phenotype did not have the mutation (Figure 7).   
 
C) C04F12.8 
B) F36H2.2 
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Figure 7: Alignment of sig-7 sequences in Prr Dpy non-Unc and non-Prr Dpy non-Unc worms Alignments 
shown are a few base pairs upstream and downstream of where mutations were expected to lie and red boxes 
indicate the location of sig-7(ku542) mutation in all of the sequences. The bottom row of each alignment shows the 
consensus sequence. The parental unc-13 dpy-24 strain was sequenced to ensure that there weren’t any parental 
mutations in sig-7. Two worms of each phenotype were sequenced. 
 
 
Discussion 
 
Prr Worms Inhibit the Effects of RNAi in the Somatic Gonad 
Characterization experiments of the effects of the RNAi on Prr worms indicate that the Prr 
mutation is not specifically related to the acs-1 gene but conveys tissue-specific RNAi resistance 
in the somatic gonad (summarized in Figure 8). RNAi assays have shown that Prr worms are not 
only resistant to acs-1(RNAi) but the RNAi of many other genes that are primarily expressed in 
the somatic gonad (gon-1and  fkh-6) and genes that are ubiquitously expressed in tissues 
including the somatic gonad (sptl-1, arf-1,2, and fasn-2). RNAi of one of these genes dyn-1 still 
had an effect on worms but they were not as severe, which may indicate that while expression of 
these genes is blocked in certain tissues, the continued expression in the somatic gonad might 
lead to a less severe phenotype. Two genes, pha-4 and mex-3 are expressed in the somatic gonad 
but RNAi of these genes still had the same effect on Prr worms as N2. It is likely that knocking 
these genes out in the other tissues that they are expressed in is sufficient to result in a 
phenotype. Two genes, car-1 and K07C5.4, actually had a more severe phenotype when knocked 
out in Prr worms. While these two experiments need to be repeated, it is possible that the RNAi 
machinery that is impaired in Prr worms that causes RNAi resistance may also convey RNAi 
sensitivity in other tissues or that Prr is somehow related to these genes.  
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Figure 8: Summary of RNAi data: Plus signs (+) indicate the observation of a phenotype, negative signs 
(-) indicate no phenotype. The number of plus signs indicates the severity of the phenotype. Boxes 
indicate where N2 phenotype differs from Prr. 
   
Dr. Kniazeva has also shown in the visualization of the effects of acs-1 (RNAi) on the worms that 
this resistance most likely works by blocking the silencing effects of RNAi in the somatic gonad. 
It appears that the Prr mutation is somehow inhibiting the silencing effects of RNAi specifically 
in the somatic gonad. We know that this is not simply a defect of siRNA spreading from the 
intestine after feeding to other tissues because Prr worms were susceptible to the effects of other 
tissue-specific RNAi‟s such as dpy-11 and unc-22,  that affected the germline and muscle 
respectively.  
 
Additional experiments that could help further characterize the Prr mutation include making an 
acs-1 Prr double mutant and observing the phenotype to see if Prr truly has no correlation with 
the acs-1 gene. I plan on repeating the ACS-1::GFP visualization experiments to confirm the 
initial observation with an N2 control that has the acs-1::GFP integration as well.  Also, we 
could look at the effects of GFP (RNAi) against the acs-1::GFP expressed in the integrated 
worms. If GFP is still expressed in the somatic gonad of worms exposed to GFP(RNAi) but not 
anywhere else, then it would be further indication that the Prr mutation conveys somatic gonad 
specific RNAi resistance that is not specifically related to acs-1. Determining the exact nature of 
the effects of RNAi on Prr mutants could reveal a novel gene involved in dsRNA-mediated gene 
silencing.    
 
 
The Prr Mutation is most Likely Due to a Mutation in the sig-7 gene 
I have also determined that the RNAi resistance caused by Prr is most likely due to a mutation in 
the gene F39H2.2, commonly known as sig-7. I will refer to the specific sig-7 mutation found in 
Seng 20 
 
Prr worms as sig-7(ku542) to indicate the allele of this gene found in Prr worms. According to 
the whole genome sequencing data, sig-7(ku542) is the only gene with a missense mutation in 
the mutated region identified by genetic mapping. The fact that the sig-7(ku542) mutation is 
present in Prr Dpy non-Unc recombinants and not non-Prr Dpy non-Unc worms is also a strong 
indicator that sig-7 is our gene of interest.  Of course, without cloning the gene, I cannot 
definitively say that sig-7 is indeed the gene that is mutated in the Prr strain. Thus, a key future 
experiment will be to express a wild-type copy of sig-7 in Prr worms to see if acs-1(RNAi) 
resistance phenotype is lost. If it turns out that sig-7 is not the mutation, there are ten nongenic 
(noncoding region) mutations in the area of interest that can be further investigated.   
 
If sig-7 is indeed the gene responsible for somatic gonad RNAi resistance, there is some 
information that can tell us how it may be involved in the mechanism of RNAi in C. elegans. sig-
7 is rather uncharacterized cyclophilin that is conserved among Drosophila, mice and humans. It 
can function as a peptidyl prolyl cis/trans isomerase to regulate protein activity and it also has an 
RNA Recognition Motif (RRM) which indicates that it can also interact with RNAs(Ratliff et al. 
2006). sig-7 has been observed by Dr. Tom Ratliff and his colleagues to play a role in silencing 
transgenes that are expressed in the germline. They identified sig-7 in a screen for genes that 
affected GFP transgene silencing in the germline. They found that a mutation in RRM of sig-7 
led to de-silencing of the transgene in the germline. Ratliff hypothesized that sig-7 plays a role in 
a mechanism of transgene repression in both germ and somatic cells (2005). Ratliff made other 
observations in 2006 that are important to understanding how sig-7 may function as a transgene 
silencer. He found that attempts to silence transgenes expressed in somatic tissues with RNAi 
enhancement mutations in sig-7 mutants failed. This indicated that sig-7 acts post-
transcriptionally. sig-7 worms tend to be sick with many developmental defects such as 
embryonic lethality and sterility. As a result, it has been hypothesized that SIG-7 may also play a 
role in regulating miRNAs that dictate development in worms (Ratliff et al. 2006).  
 
Thus, it appears that sig-7 interacts with RNAs in the germline and somatic tissues. Given the 
fact that attempts to silence somatic transgenes with RNAi enhancement mutations failed in sig-7 
mutant, sig-7 appears to be an even more likely candidate for the gene that is mutated in Prr 
worms, as it seems that the Prr mutation conveys RNAi resistance in the somatic gonad. 
However, it must keep in mind that if sig-7(ku542) is indeed the mutated gene in Prr worms it is 
not likely a loss of function mutation or a mutation in an RRM because Prr worms do not have 
any of the developmental defects associated with a sig-7 mutation in the RRM described in the 
literature. The missense mutation also isn‟t very severe as it is change from an arginine, a 
positively charged amino acid, to another positively charged amino acid, lysine in the seventh 
exon (Figure 9 and 10).  Also, RNAi resistance is specific to the somatic gonad and not other 
somatic tissues as observed by Ratliff. Thus, it is possible that the amino acid change in ku542 
alters SIG-7 function or structure so that RNAi effects are inhibited in only the somatic gonad 
and it is able to carry out its miRNA regulation so development in worms is normal.  
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Figure 9: sig-7 gene and location of the exon with the ku542 allele (outlined in red) (Adapted from 
Wormbase.org; http://wormbase.org/db/gene/gene?name=WBGene00000890;class=Gene) 
 
 
 
 
Figure 10: The SIG-7 protein and the location of the ku542 allele (indicated by the asterisk) (Adapted from 
Wormbase.org; http://wormbase.org/db/seq/protein?name=WBGene00000890;class=Gene) 
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If sig-7(ku542) is our mutation of interest, to determine its mechanism, we could first identify 
synthetic suppressors through an EMS mutagenesis screen. This screen would involve inducing 
random mutations in sig-7(ku542) worms by exposing them to ethyl methanesulfonate (EMS), a 
chemical mutagen. Then we would select worms with secondary mutations that reverse the Prr 
phenotype. Mapping and identifying the gene or genes involved in this secondary mutation 
would reveal genes and gene products involved in SIG-7 function and perhaps identify a cellular 
pathway it is involved in. We could also try to identify the significance of the mutated residue in 
sig-7(ku542) mutants. The mutation does not appear to be in the predicted RNA binding domains 
(NCBI). We could try changing the mutated amino acid to different types of amino acids (polar, 
nonpolar, negatively charged, etc.) to see if it has any effects on the phenotype. If the phenotype 
changes, then we know that this particular amino acid is very important to SIG-7 function or 
structure. To see if sig-7 has any relation to the somatic gonad patterns we saw in the 
characterization data, we could also make a sig-7 Promoter GFP reporter to determine if sig-7 is 
expressed specifically in the somatic gonad. We must also remember that SIG-7 is a well-
conserved cyclophilin, thus looking into its functions in other organisms could reveal much 
about how it functions in worms.    
 
Somatic Gonad-Specific RNAi Resistance in Relation to the acs-1 gene 
In regards to what we have learned about the rather enigmatic acs-1 gene from this study, it 
appears that the data we have collected fits well with the current model of acs-1 function that 
exists. ACS-1 is thought to have various functions and different transcripts to carry out these 
different functions. It has been identified that the acs-1 mRNA that is transcribed in the somatic 
gonad may be shorter than the transcript in the intestine. It is believed that ACS-1 in the intestine 
functions to produce C17ISO that is crucial for development and growth of worms and ACS-1 in 
the somatic gonad actually blocks the transport to the embryo of a lipid that negatively regulates 
embryo development (Figure 11) (Kniazeva, unpublished data). Thus, acs-1 (RNAi) on its own 
leads to larval arrest of the P0 generation worms because they lack the C17ISO needed to 
develop. acs-1(RNAi) with C17ISO on the other hand provides P0‟s with the lipids needed to 
develop but the C17ISO is also incorporated into the negative-effector lipids. Without ACS-1 to 
block these negative-effector lipids from entering the embryo, embryos are unable to develop 
and they arrest. In Prr worms growing on acs-1(RNAi) plates with C17ISO, ACS-1 is still 
expressed in the somatic gonad, thus the ACS-1 being expressed is able to block the negative 
lipid and allow embryonic development and proliferation of the strain. 
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Figure 11: The current model for ACS-1 function in worms (Kniazeva). 
 
Further Questions and Significance 
The results of this study have presented new questions in need of further investigation. Is sig-7 
truly responsible for the RNAi resistance observed in Prr worms? If so, how does it convey this 
resistance and how does the sig-7 (ku542) allele actually affect the function of the protein? If not, 
what other mutations could possibly cause this phenotype? Given the conservation of the SIG-7 
cyclophilin across a broad range of organisms, the investigation of this gene and its role in gene 
regulation has the potential to yield exciting and practical conclusions regarding the mechanism 
of RNAi. The somatic gonad-specific RNAi resistance of Prr worms may provide a useful tool 
for studying the somatic gonad in C. elegans. We also stand to learn more about the acs-1 gene 
and whether or not the proposed model of function is accurate or not. Further studies of this 
unique mutant strain serve to provide significant insight on two fascinating and enigmatic 
cellular mechanisms.  
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